This session highlights cutting-edge research and innovative approaches in neuroimmunology drug development, featuring advances in biomarker identification, translational models, target validation, and early-phase clinical studies. Join us to explore the latest strategies driving therapeutic innovation for neuroinflammatory and neurodegenerative diseases.